Literature DB >> 843512

Senile disciform macular degeneration in the second eye.

Z Gregor, A C Bird, I H Chisholm.   

Abstract

Development of senile disciform degeneration in the second eye was studied in a group of 104 patients over a period of up to five years. 12 to 15% of these patients develop disciform degeneration in the other eye each year. Patients with large and confluent drusen, especially if combined with accumulation of dye on fluorescein angiogram, were at greatest risk of developing disciform degeneration in the second eye.

Entities:  

Mesh：

Year:  1977        PMID： 843512      PMCID： PMC1042899          DOI： 10.1136/bjo.61.2.141

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  6 in total

1.  Senile choroidal vascular patterns and drusen.

Authors:  E FRIEDMAN; T R SMITH; T KUWABARA
Journal:  Arch Ophthalmol       Date:  1963-02

2.  Ageing and degeneration in the macular region: a clinico-pathological study.

Authors:  S H Sarks
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

3.  Natural history of disciform degeneration of the macula.

Authors:  S R Chandra; E S Gragoudas; E Friedman; E M Van Buskirk; M L Klein
Journal:  Am J Ophthalmol       Date:  1974-10       Impact factor: 5.258

4.  The development of neovascularization of senile disciform macular degeneration.

Authors:  V W Teeters; A C Bird
Journal:  Am J Ophthalmol       Date:  1973-07       Impact factor: 5.258

5.  Drusen and disciform macular detachment and degeneration.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1973-09

6.  New vessel formation beneath the retinal pigment epithelium in senile eyes.

Authors:  S H Sarks
Journal:  Br J Ophthalmol       Date:  1973-12       Impact factor: 4.638
  6 in total
  33 in total

1.  Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage.

Authors:  Sven Erik G Nilsson; Staffan P Sundelin; Ulf Wihlmark; Ulf T Brunk
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

2.  CNV subtype in first eyes predicts severity of ARM in fellow eyes.

Authors:  S Abugreen; K A Muldrew; M R Stevenson; R VanLeeuwen; P T V M DeJong; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

3.  Detection of subpigment epithelial neovascularisation in cases of retinal pigment epithelial detachments: a review of the Moorfields treatment trial.

Authors:  S Pagliarini; M J Barondes; I H Chisholm; A M Hamilton; A C Bird
Journal:  Br J Ophthalmol       Date:  1992-01       Impact factor: 4.638

Review 4.  Bruch's membrane change with age.

Authors:  A C Bird
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

Review 5.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

6.  Symmetry of disciform scars in bilateral age-related macular degeneration.

Authors:  M J Lavin; B Eldem; Z J Gregor
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

Review 7.  25th RCOphth Congress, President's Session paper: 25 years of progress in medical retina.

Authors:  J M Gibson
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

8.  Natural history of subfoveal pigment epithelial detachments associated with subfoveal or unidentifiable choroidal neovascularization complicating age-related macular degeneration.

Authors:  L J Singerman; J H Stockfish
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

9.  Senile disciform macular degeneration.

Authors: 
Journal:  Br Med J       Date:  1979-06-02

10.  Asymmetry of disciform scarring in bilateral disease when one eye is treated with radiotherapy.

Authors:  P M Hart; D B Archer; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.